Profilo
Alice Chen is currently the Director at Automera Pte Ltd.
She is also currently the Executive Vice President at Accelerator Services Corp.
Previously, she worked as the Director at Qwell Pharmaceuticals, Inc. Dr. Chen holds a doctorate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.
Posizioni attive di Alice Chen
Società | Posizione | Inizio |
---|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investitore di Private Equity | 01/01/2017 |
Precedenti posizioni note di Alice Chen
Società | Posizione | Fine |
---|---|---|
Qwell Pharmaceuticals, Inc.
Qwell Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Qwell Pharmaceuticals, Inc. developed small molecule drugs for oncology indications. It was a start-up biotechnology company devoted to small-molecule development derived from a plant source that have a potent ability to fight tumors and excess inflammation of skin cells. The company was founded in 2008 and was headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - |
Formazione di Alice Chen
University of California, Berkeley | Undergraduate Degree |
Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Qwell Pharmaceuticals, Inc.
Qwell Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Qwell Pharmaceuticals, Inc. developed small molecule drugs for oncology indications. It was a start-up biotechnology company devoted to small-molecule development derived from a plant source that have a potent ability to fight tumors and excess inflammation of skin cells. The company was founded in 2008 and was headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Alice Chen